Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)

Key facts

Sponsor

Johann Wolfgang Goethe University Hospital

Principal Investigator

Stefan Zielen, Prof. Dr.

Children´s Hospital, Goethe-University

Intervention

Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate(drug)

Enrollment

24 enrolled

Eligibility

3-18 years · All sexes

Timeline

2010 – 2012

Study locations (1)

• Children's Hospital, Goethe-University, Frankfurt am Main, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →